CL2009002112A1 -
A compound derived from carbamoyloxy-arylalkanoyl-arylpiperazine; pharmaceutical composition comprising said compound, useful for the treatment of pain, anxiety or depression.
- Google Patents
A compound derived from carbamoyloxy-arylalkanoyl-arylpiperazine; pharmaceutical composition comprising said compound, useful for the treatment of pain, anxiety or depression.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sk Biopharmaceuticals Co LtdfiledCriticalSk Biopharmaceuticals Co Ltd
Priority to CL2009002112ApriorityCriticalpatent/CL2009002112A1/en
Publication of CL2009002112A1publicationCriticalpatent/CL2009002112A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Un compuesto derivado de carbamoiloxi-arilalcanoil-arilpiperazina; composición farmacéutica que comprende a dicho compuesto, útil para el tratamiento del dolor, la ansiedad o la depresión.A compound derived from carbamoyloxy-arylalkanoyl-arylpiperazine; pharmaceutical composition comprising said compound, useful for the treatment of pain, anxiety or depression.
CL2009002112A2009-11-202009-11-20
A compound derived from carbamoyloxy-arylalkanoyl-arylpiperazine; pharmaceutical composition comprising said compound, useful for the treatment of pain, anxiety or depression.
CL2009002112A1
(en)
A compound derived from carbamoyloxy-arylalkanoyl-arylpiperazine; pharmaceutical composition comprising said compound, useful for the treatment of pain, anxiety or depression.
A compound derived from carbamoyloxy-arylalkanoyl-arylpiperazine; pharmaceutical composition comprising said compound, useful for the treatment of pain, anxiety or depression.
A compound derived from carbamoyloxy-arylalkanoyl-arylpiperazine; pharmaceutical composition comprising said compound, useful for the treatment of pain, anxiety or depression.
COMPOUNDS DERIVED FROM ISOXAZOLIDINE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND, USEFUL FOR THE TREATMENT OF ASSOCIATED DISORDERS WITH HYPERPROLIFERATION AS CANCER.
Compounds derived from 3-hydroxy-5-arylisothiazole, agonists of receptor 40 coupled to protein g (gpr40); pharmaceutical composition comprising them; and method for the treatment or prevention of diabetes.
Compounds derived from n- (1-4- (1h-pyrazol-5-yl) phthalazine-1-yl) piperidine-4-yl) benzamide; pharmaceutical composition that contains them, useful as antagonist of the hedgehog trajectory, in the treatment of cancer.
Compounds derived from 3-benzoisoxazole-piperidine; pharmaceutical composition comprising said compounds; and its use for the treatment and / or prevention of cognitive disorders, drug addiction, depression, anxiety, among others.
Compounds derived from phenylamino-isonicotinamide; mek inhibitors; Pharmaceutical composition and use for the treatment of hyperproliferative diseases such as cancer and inflammation.
Compounds derived from indolinones; pharmaceutical composition comprising said compound; and use of the compound for the treatment and / or prevention of cancer, infections, inflammatory and autoimmune diseases.
Compounds derived from indolinones; pharmaceutical composition comprising said compound; and use of the compound for the treatment of cancer, infections, inflammatory and autoimmune diseases.
Compounds derived from disubstituted tetrahydrofuranyl and its salts, as antagonists of the b1 receptor of bradykinin; medicament containing said compounds; its preparation procedure, useful for the acute or prophylactic treatment of acute pain, osteoarthritis, asthma, allergies, among other diseases.
Compounds derived from substituted amino-quinazolines; pharmaceutical composition comprising said compound; and use of the compound for the treatment of Alzheimer's.